Literature DB >> 33632817

Liver homeostasis is maintained by midlobular zone 2 hepatocytes.

Yonglong Wei1, Yunguan G Wang1,2, Yuemeng Jia1, Lin Li1, Jung Yoon1, Shuyuan Zhang1, Zixi Wang1, Yu Zhang3, Min Zhu1, Tripti Sharma3, Yu-Hsuan Lin1, Meng-Hsiung Hsieh1, Jeffrey H Albrecht4,5, Phuong T Le6, Clifford J Rosen6, Tao Wang2, Hao Zhu7,3.   

Abstract

The liver is organized into zones in which hepatocytes express different metabolic enzymes. The cells most responsible for liver repopulation and regeneration remain undefined, because fate mapping has only been performed on a few hepatocyte subsets. Here, 14 murine fate-mapping strains were used to systematically compare distinct subsets of hepatocytes. During homeostasis, cells from both periportal zone 1 and pericentral zone 3 contracted in number, whereas cells from midlobular zone 2 expanded in number. Cells within zone 2, which are sheltered from common injuries, also contributed to regeneration after pericentral and periportal injuries. Repopulation from zone 2 was driven by the insulin-like growth factor binding protein 2-mechanistic target of rapamycin-cyclin D1 (IGFBP2-mTOR-CCND1) axis. Therefore, different regions of the lobule exhibit differences in their contribution to hepatocyte turnover, and zone 2 is an important source of new hepatocytes during homeostasis and regeneration.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33632817     DOI: 10.1126/science.abb1625

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Assessment of Hepatocyte Ploidy by Flow Cytometry.

Authors:  Yinhua Jin; Teni Anbarchian; Roel Nusse
Journal:  Methods Mol Biol       Date:  2022

2.  FoxO3 restricts liver regeneration by suppressing the proliferation of hepatocytes.

Authors:  Chi-Qian Liang; Deng-Cheng Zhou; Wen-Tao Peng; Wu-Yun Chen; Hai-Yan Wu; Yi-Min Zhou; Wei-Li Gu; Kyu-Sang Park; Hui Zhao; Long-Quan Pi; Li Zheng; Shan-Shan Feng; Dong-Qing Cai; Xu-Feng Qi
Journal:  NPJ Regen Med       Date:  2022-06-24

3.  Significance of Liver Zonation in Hepatocellular Carcinoma.

Authors:  Shizhe Yu; Jie Gao; Haoren Wang; Long Liu; Xudong Liu; Yuantong Xu; Jihua Shi; Wenzhi Guo; Shuijun Zhang
Journal:  Front Cell Dev Biol       Date:  2022-06-23

4.  Insulin-like growth factor binding protein 2 null mice (Igfbp2-/-) are protected against trabecular bone loss after vertical sleeve gastrectomy.

Authors:  Benjamin T Harris; Phuong T Le; Janaina Da Silva Martins; Lama Alabdulaaly; Roland Baron; Mary L Bouxsein; Clifford J Rosen; Alison N Pletch
Journal:  Surg Endosc       Date:  2022-02-28       Impact factor: 3.453

5.  A breakthrough in liver regeneration for treatment of liver cancer.

Authors:  Hao Xu; Yisheng Pan; Ning Zhang
Journal:  Cancer Biol Med       Date:  2021-08-15       Impact factor: 5.347

Review 6.  The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.

Authors:  Maruhen A D Silveira; Steve Bilodeau; Tim F Greten; Xin Wei Wang; Giorgio Trinchieri
Journal:  Trends Cancer       Date:  2022-03-21

7.  Hierarchical Hydrogels with Ordered Micro-Nano Structures for Cancer-on-a-Chip Construction.

Authors:  Luyao Zhu; Changmin Shao; Hanxu Chen; Zhuoyue Chen; Yuanjin Zhao
Journal:  Research (Wash D C)       Date:  2021-12-26

8.  The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling.

Authors:  Jinrui Dong; Sivakumar Viswanathan; Eleonora Adami; Sebastian Schafer; Fathima F Kuthubudeen; Anissa A Widjaja; Stuart A Cook
Journal:  Elife       Date:  2021-08-26       Impact factor: 8.140

Review 9.  Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.

Authors:  Takahide Ara; Daigo Hashimoto
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

Review 10.  The Liver-Immunity Nexus and Cancer Immunotherapy.

Authors:  James C Lee; Michael D Green; Laura A Huppert; Christine Chow; Robert H Pierce; Adil I Daud
Journal:  Clin Cancer Res       Date:  2021-07-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.